1Noguchi M,Morikawa A,Kawasaki M,et al.Small adenocarcinoma of the lung:Histologic characteristics and prognosis.Cancer,1995,75:2844-2852.
2Yousem SA,Beasley MB.Bronchioloalveolar carcinoma:a review of current concepts and evolving issues.Arch Pathol Lab Med,2007,131:1027-1032.
3Raz DJ,He B,Rosell R,et al.Current concepts in bronchioloalveolar carcinoma biology.Clin Cancer Res,2006,12:3698-3704.
4Read WL,Page NC,Tierney RM,et al.The epidemiology of bronchioloalveolar carcinoma over the past two decades:analysis of the SEER database.Lung Cancer,2004,45:137-142.
6Raz DJ,Jablons BM.Bronchioloalveolar carcinoma is not associated with younger age at diagnosis:an analysis of the SEER database.J Thorac Oncol,2006,1:339-343.
8Kitazaki T,Fukuda M,Soda H,et al.Novel effects of gefitinib on mucin production inbronchioloalveolar carcinoma:two case reports.Lung Cancer,2005,49:125-128.
9Raz DJ,Kim JY,Jablons DM.Diagnosis and treatment of bronchioloalveolar carcinoma.Curr Opin Pulm Med,2007,13:290-296.
10Arenberg D.Bronchioloalveolar lung cancer:ACCP Evidence-based clinical practice guidelines (2nd edition).Chest,2007,132:306-313.
二级参考文献13
1Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours[J]. Eur Respir J, 2001,18:1059-1068.
2Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors [J]. Semin in Roentgenol, 2005,40(2) : 90-97.
3Kris MG, Sandler A, Miller V, et al. Cigarette smoking history predicts sensitivity to erlotinib: Results of a phase Ⅱ trial in patients with bronchioloalveolar cacinoma (BAC) [J].Proc Am Soc Clin Oncol, 2004,23:631S.
4Jackman DM, Chirieac LR, Janne PA. Bronchioloalveolar carcinoma: A review of the epidemiology, pathology, and treatment [J]. Semin Respir Crit Care Med, 2005,26 (3):342-352.
5Ebright MI, Zakowski MF, Martin J, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma [J ]. Ann Thorac Surg, 2002,74(5) : 1640-1646.
6Furak J, Trojan I, Szoke T, et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival [J]. Eur Cardiothorac Surg, 2003,23 : 818-823.
7Roberts PF, Straznicka M, Lara PN, et al. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved [J]. J Thorac Cardiovasc Surg, 2003,126: 1597-1601.
8West HL, Crowley J J, Vance RB, et al. Advanced brocnhioloalveolar carcinoma: A phase Ⅱ trial of paclitaxel by 96-hour infusion (SWOG 9714) [J]. Ann Oncol : in press.
9West H, Franklin WA, McCoy J, et al. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126 [J]. J Clin Oncol, 2006,24(12):1807-1813.
10Lee DH, Han JY, Lee HG, et al. Gefitinib as a first-line therapy of advanced or metastatic adenocarcinoma of the lung in never-smokers [J]. Clin Cancer Res, 2005,11 (8) :3032-3037.
